Podcast
Questions and Answers
What is the main focus of Module 1016 Pharmacogenomics?
What is the main focus of Module 1016 Pharmacogenomics?
- Understanding the application of pharmacogenomics in clinical practice (correct)
- Identifying key genes compromising safety in Oncology treatments
- Reviewing the discovery of the CFTR gene
- Exploring the impact of genomics on Cystic Fibrosis
What is the significance of the CFTR gene in the context of Genomic Medicine?
What is the significance of the CFTR gene in the context of Genomic Medicine?
- It is a key gene compromising safety in Oncology treatments
- It has no significant impact on the CF population
- It is a crucial discovery with impact on the CF population (correct)
- It plays a minimal role in pharmacogenomics
What makes up a person's genome?
What makes up a person's genome?
- 3.2 billion bases of DNA (correct)
- Genomic medicine and pharmacogenomics
- Proteins and amino acids
- Variations between individuals
What percentage of the genome is the same in everyone?
What percentage of the genome is the same in everyone?
What does pharmacogenomics study?
What does pharmacogenomics study?
What is the role of gene in making up an individual?
What is the role of gene in making up an individual?
What is the main cause of DPD deficiency?
What is the main cause of DPD deficiency?
Which of the following toxicities is not associated with the treatment of patients with DPD deficiency?
Which of the following toxicities is not associated with the treatment of patients with DPD deficiency?
Which gene is associated with increased toxicity in colorectal cancer patients treated with Irinotecan?
Which gene is associated with increased toxicity in colorectal cancer patients treated with Irinotecan?
Which variant tested on the NHS is associated with a 50% DPD activity and requires a 50% dose reduction or alternative therapy?
Which variant tested on the NHS is associated with a 50% DPD activity and requires a 50% dose reduction or alternative therapy?
What is the consequence of NUDT15 gene mutations in Acute lymphoblastic Leukemia patients treated with 6-mercaptopurine and thioguanine?
What is the consequence of NUDT15 gene mutations in Acute lymphoblastic Leukemia patients treated with 6-mercaptopurine and thioguanine?
Which drug is associated with decreased efficacy in breast cancer patients with defects in the CYP2D6 gene?
Which drug is associated with decreased efficacy in breast cancer patients with defects in the CYP2D6 gene?
What should be considered when contemplating supportive care medications, according to the information provided?
What should be considered when contemplating supportive care medications, according to the information provided?
What is the association of G6PD gene mutations in hematological cancer patients treated with Rasburicase?
What is the association of G6PD gene mutations in hematological cancer patients treated with Rasburicase?
Which pharmacogenetic test is associated with increased toxicity in acute lymphoblastic leukemia patients treated with 6-mercaptopurine and thioguanine?
Which pharmacogenetic test is associated with increased toxicity in acute lymphoblastic leukemia patients treated with 6-mercaptopurine and thioguanine?
What is the main focus of Genomics in rare disease diagnosis?
What is the main focus of Genomics in rare disease diagnosis?
Which cells are affected by Cystic Fibrosis (CF)?
Which cells are affected by Cystic Fibrosis (CF)?
When was the CFTR gene discovered?
When was the CFTR gene discovered?
How many amino acids is the CFTR channel composed of?
How many amino acids is the CFTR channel composed of?
What is the main focus of Pharmacogenomics?
What is the main focus of Pharmacogenomics?
Which of the following is a CFTR modulator therapy used to treat CF?
Which of the following is a CFTR modulator therapy used to treat CF?
What is the foundation of national pharmacogenetic testing?
What is the foundation of national pharmacogenetic testing?
Which cancers are predominantly prescribed DPD-related medications?
Which cancers are predominantly prescribed DPD-related medications?
Study Notes
- Genomics plays a significant role in rare disease diagnosis, comparison of whole genome sequencing (WGS) of patients with the same condition to reveal patterns, and targeted treatments.
- Cystic Fibrosis (CF) is an inherited disorder that affects the cells producing mucus, sweat, and digestive juices, damaging the lungs, digestive system, and other organs.
- CF was discovered in the 1980s, and therapy now targets genes dysfunctionalities.
- The CFTR gene was discovered in 1989, raising hope, identifying over 2000 mutations, and improving diagnosis and management of CF.
- CFTR is a phosphorylation-regulated Cl- channel composed of 1480 amino acids organized into five functional domains. Proper functionality of these domains is needed for channel activity.
- Pharmacogenomics deals with how a patient's genome influences how they respond to medicines.
- CFTR modulator therapies, such as Kalydeco® (ivacaftor), Orkambi® (lumicaftor/ivacaftor), Symkevi® (tezacafor/ivacaftor), and triple therapy (Kaftrio® - elexacafor/tezacaftor/ivacaftor), are used to treat CF.
- Pharmacogenetic testing, such as DPYD for Fluoropyrimidines, is the foundation of national pharmacogenetic testing. DPD, an enzyme coded for by the DPYD gene, plays a role in the metabolism of 5-fluorouracil, capecitabine, and tegafur, and is predominantly prescribed for gastrointestinal, breast, and head and neck cancers.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Explore the practical applications of pharmacogenomics (PGx) in clinical practice, with a focus on genomic variability in Cystic Fibrosis and key genes affecting safety in Oncology treatments. This lecture series provides an overview of genomics and its real-world applications.
